We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 793 start-ups with an aggregate funding of $7.5b. The average funding per company in this subset is $108.8m.
Last update to the database: Feb 18, 2025. See changelog.
A genetic medicine company that build data platforms using synthetic biology, artificial intelligence and genetic medicine for the development of medical therapies.
5
Funding Rounds
$236.7m
Money raised
Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases
6
Funding Rounds
$356.3m
Money raised
Leo Cancer Care is a company developing upright radiotherapy solutions.
1
Funding Rounds
$25.3m
Money raised
A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.
5
Funding Rounds
$76.5m
Money raised
Senti Biosciences is a synthetic biology company.
2
Funding Rounds
$158.0m
Money raised
A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018.
4
Funding Rounds
$153.7m
Money raised
Paige provides AI-based digital diagnostics and a vendor-neutral platform designed to drive diagnostic confidence and a more productive pathology workflow.
10
Funding Rounds
$410.0m
Money raised
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.
1
Funding Rounds
$225.0m
Money raised
A biotechnology company that develops medicines based on live bacterial consortia that can colonize the human intestine.
13
Funding Rounds
$386.6m
Money raised
RoosterBio is a biotechnology company located in Frederick, Maryland, founded by Jon Rowley in 2013 providing standardized stem cell products for R&D, clinical, and commercial use in the regenerative medicine industry.
3
Funding Rounds
$21.5m
Money raised
Neos Therapeutics is a pharmaceutical company developing ADHD medications founded in 2008.
1
Funding Rounds
$24.1m
Money raised
Cala Health offers bioelectronic medicines, medical devices, and neurotherapeutics for managing chronic health conditions.
3
Funding Rounds
$145.0m
Money raised
Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.
6
Funding Rounds
$190.5m
Money raised
Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.
5
Funding Rounds
$103.1m
Money raised
Massive Bio is a New York-based company founded by Selin Kurnaz, Dr. Arturo Loaiza-Bonilla and Cagatay M. Culcuoglu, offering precision oncology services to cancer patients, providers, and pharmaceutical companies.
6
Funding Rounds
$15.8m
Money raised
Biotherapeautics company founded in 2014 and based in Paris that uses proprietary methods in synthetic biology, protein and genome engineering to produce Eligobiotics, products which intervene with the microbiome as diagnostics, antimicrobials and modulators of host-microbiome interactions.
9
Funding Rounds
$82.6m
Money raised
A biopharmaceutical company developing therapeutics to attack cancer stem cells.
2
Funding Rounds
$13.8m
Money raised
miRagen is a clinical stage biopharmaceutical company developing innovative microRNA-targeting therapies to improve human health.
3
Funding Rounds
$32.0m
Money raised
A company developing anti-aging treatments using components derived from human blood.
3
Funding Rounds
$41.0m
Money raised
Nanomedicine company developing vaccines and therapies with cell-specific targeting.
6
Funding Rounds
$4.6m
Money raised
ApexQubit is a biotechnology company that is harnessing a proprietary technology for discovery of new medicines to treat patients with undruggable diseases.
3
Funding Rounds
$54.1k
Money raised
Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology.
6
Funding Rounds
$86.6m
Money raised
A medical company in Massachusetts focusing on lowering the cost of vaccine distribution.
14
Funding Rounds
$87.2m
Money raised
An exosome therapeutics company founded in 2016 and based in Oxford, UK, that uses exosomes to deliver small and large molecule therapeutics. The company has a proprietary technology to modify exosomes to target specific organs such as the brain and central nervous system.
3
Funding Rounds
$143.4m
Money raised
Cellink AB is a biotechnology research company based in Gothenburg.
2
Funding Rounds
$4.5m
Money raised
A therapeutics company founded in 2016 working in drug discovery and development using fungi. LifeMine uses genomics approaches to search for biosynthetic genes in eukaryotic microbes for the discovery of naturally inspired drugs to treat previously untreatable and significant chronic diseases.
3
Funding Rounds
$280.0m
Money raised
Lung Therapeutics is a therapeutics for lung injury and disease company founded in 2013 by Andrew Mazar, Steven Idell and Sreerama Shetty.
2
Funding Rounds
$50.3m
Money raised
A biotechnology company that develops treatments for cancer and hematologic conditions
2
Funding Rounds
$18.1m
Money raised
Antheia is an American biotechnology company founded in 2013, and is located in Menlo Park, California. Antheia uses synthetic biology, informatics, and fermentation technologies to produce plant based medicines; most notably opioids using yeast.
1
Funding Rounds
$73.0m
Money raised
A biotechnology company developing live attenuated vaccines. It was founded in 2012 and is located in New York.
5
Funding Rounds
$26.8m
Money raised
Leader in delivering real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.
6
Funding Rounds
$230.6m
Money raised
Dharmacon, Inc. is a Lafayette, Colorado-based company founded in 1995.
Avro is a life sciences company, located in Canada and founded in 2016 by Shakir Lakhani and Keean Waterloo, Ontario, that makes skin patches capable of delivering generic drugs.
2
Funding Rounds
$120.0k
Money raised
3T Biosciences is a biotechnology company developing immunotherapies.
3
Funding Rounds
$52.0m
Money raised
SmartPharm Therapeutics is a Cambridge, MA-based gene therapy company applying the next generation of non-viral DNA and RNA technologies to treat serious human diseases.
1
Funding Rounds
$10.5m
Money raised
Formerly BioMedicines, Intarcia Therapeutics is an American biopharmaceutical company developing therapies for diseases with long-term treatment requirements.
4
Funding Rounds
$479.5m
Money raised
Oxford Drug Design Limited is a company that focuses on developing and delivering services and technologies for computer-aided drug discovery
5
Funding Rounds
$10.0m
Money raised
Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.
5
Funding Rounds
$425.0m
Money raised
Palvella Therapeutics is committed to developing safe and effective therapies that specifically target the root cause of genetic skin diseases.
2
Funding Rounds
$55.0m
Money raised
Oxford Genetics, also known as Oxgene, is a synthetic biology company specializing in DNA design, protein expression optimization and cell line development technologies and services.
7
Funding Rounds
$31.4m
Money raised
An artificial intelligence company with a focus on developing solutions for the healthcare industry. It was founded in 2017 and is located in Tel Aviv, Israel.
2
Funding Rounds
$11.5m
Money raised
Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.
4
Funding Rounds
$46.7m
Money raised
CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia to deliver bioactive molecules to treat diseases associated with the human gut microbiome.
2
Funding Rounds
$645.0k
Money raised
Foundation Medicine is a Cambridge, Massachusetts-based pharmaceutical company developing diagnostic and treatment solutions for cancer care founded in 2010 by Alexis Borisy.
4
Funding Rounds
$96.5m
Money raised
A biopharmaceutical company focused on developing treatments for urea cycle disorders and other rare diseases
3
Funding Rounds
$117.5m
Money raised
Siolta Therapeutics develops microbiome analyses to test microbial-based therapeutics for the treatment and prevention of inflammatory diseases. The company was founded in 2016 by Nikole Kimes PhD.
2
Funding Rounds
$30.0m
Money raised
OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.
5
Funding Rounds
$19.7m
Money raised
Horizon Discovery is a company that offers gene editing, CRO, and diagnostics services
5
Funding Rounds
$30.9m
Money raised
64x Bio is a biotechnology company developing a platform for improving speed and scalability of mammalian cell line discovery for pharmaceutical and biotechnology companies.
3
Funding Rounds
$59.5m
Money raised
AI-powered drug discovery platform.
3
Funding Rounds
$69.5m
Money raised
Genecentric Diagnostics, Inc. is an oncology diagnostic and treatment center.
4
Funding Rounds
$13.9m
Money raised
Stelvio Therapeutics is a biotechnology company developing therapeutics for cancer.
1
Funding Rounds
A bio-data company that uses AI to analyze RNA sequencing data
2
Funding Rounds
$5.4m
Money raised
A pharmaceutical company that uses a zebrafish drug-screening platform to find drug candidate molecules that have the capacity to promote regeneration of tissues. Their drug candidate MSI-1436 is being developed and tested for the treatment of heart disease, Duchenne Muscular Dystrophy and diabetic nephropathy.
1
Funding Rounds
$4.0m
Money raised
Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.
5
Funding Rounds
$134.1m
Money raised
Snipr Biome is a synthetic biology company using CRISPR to make products for the microbiome.
2
Funding Rounds
$100.0m
Money raised
A company based in Farmington, Connecticut, that develops skin disease treatments using microbiome science and technology.
9
Funding Rounds
$56.6m
Money raised
RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.
2
Funding Rounds
$1.0b
Money raised
DCPrime is a biotechnology company developing cancer immunotherapies.
5
Funding Rounds
$26.0m
Money raised
A company utilizing BMI and Neurofeedback to optimize brain potential.
3
Funding Rounds
$6.0m
Money raised
Turbine.ai is a Budapest-based drug discovery company founded in 2015 by Daniel Veres, Kristóf Zsolt Szalay and Szabolcs Nagy.
3
Funding Rounds
$31.1m
Money raised
An institute for research at Harvard University for developing bioinspired materials and medical devices.
1
Funding Rounds
$37.0m
Money raised
JW (Cayman) Therapeutics Co. Ltd is a Shanghai-based developer of cell-based therapy technologies for cancer treatment.
2
Funding Rounds
$195.5m
Money raised
IGM Biosciences is an antibody Treatments.
2
Funding Rounds
$204.0m
Money raised
Aprinoia Therapeutics is a developer of diagnostics, therapeutics and drug discovery platform for neurological diseases.
1
Funding Rounds
$11.1m
Money raised
A biopharmaceutical company developing therapeutics for treating age-related diseases.
3
Funding Rounds
$105.0m
Money raised
Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.
2
Funding Rounds
$105.0m
Money raised
Chiasma Pharma is a Waltham, Massachusetts-based biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
3
Funding Rounds
$90.2m
Money raised
Neurelis Inc. is a private specialty pharmaceutical company based in San Diego, California, US, providing treatment options for epilepsy and central nervous system disorders.
1
Funding Rounds
$114.0m
Money raised